CMS ACCESS: A Strategic Pilot
for Pelvic MSK Integration
Implementing neuroplastic pain-science-informed self-management to improve 90-day functional outcomes for Medicare beneficiaries.
Identify
Target Pelvic MSK Track
Select patients using validated ICD-10 codes (M62.838, M79.18, M99.05).
Baseline
In-Office PEG/PCS
Administer the initial PEG/PCS questionnaires to establish the clinical necessity.
Prescribe
AVS Digital Referral
Include the 90-day PelvicSense link in the After-Visit Summary (AVS).
Close the Loop
Outcome Assessment
Receive Managed Milestone Alerts to trigger the post-assessment and document the Functional Delta
The 90-Day Clinical Curriculum
A phased, neuroplastic pain-science-informed pathway to functional recovery.
Phase 1: Education
PNE Foundation
Patients master Pain Neuroscience Education (PNE) to shift from a structural-focused to a neuroplastic-informed recovery mindset.
Phase 2: Regulation
Somatic Re-patterning
Implementation of evidence-based tools including Somatic Tracking and Graded Motor Imagery to down-regulate the nervous system.
Phase 3: Restoration
Functional Integration
Graduated breath and body movement plus lifestyle integration designed to return the patient to Daily Activities with reduced fear and increased confidence.
Master Clinician Oversight
Developed by a Master Clinician Pelvic PT with over 25 years of specialization in complex chronic pelvic pain and desensitization protocols
Proven Pilot Results
Initial pilot data demonstrates significant 3-point reductions in Pain Intensity and reduced Catastastrophizing (PCS) scores across diverse pelvic participants
Evidence-Based Validation
Efficacy is being evaluated via an active Randomized Controlled Trial (RCT), ensuring the curriculum meets the highest clinical standards
Federal-Grade Vetting
Currently in the Veterans Administration (VA) procurement pipeline for system-wide pelvic health integration to support veteran recovery
Secure Your Clinic’s CMS ACCESS Readiness
Improve patient outcomes and support busy providers with our seamless, no-PHI clinical integration.
We are currently accepting a limited number of clinical partners for our 2026-7 Strategic Pilot. This phase is designed for forward-thinking Medical Directors who prioritize longitudinal functional outcomes and audit-ready documentation without the burden of complex IT onboarding.
Through our Managed Oversight model, your clinic maintains full clinical control while offloading the 90-day recovery curriculum to our proven framework. By incorporating PelvicSense into your existing After-Visit Summary (AVS), you leverage four years of proprietary data to ensure your Medicare beneficiaries receive the gold standard in neuroplastic pain-science education."
To maintain the clinical integrity of our 2026 Strategic Pilot framework, the Executive Summary is provided via professional correspondence.
Please enter your details below to receive the prospectus and access our clinical discovery calendar.
